USE OF COMPOUNDS BINDING TO THE SIGMA RECEPTOR LIGANDS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A CONSEQUENCE OF CHEMOTHERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15402867

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention refers to the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from chemotherapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ESTEVE PHARMACEUTICALS S APASSEIG DE LA ZONA FRANCA 109 4ª PLANTA TORRE ESTEVE BARCELONA 08038

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baeyens-Cabrera, José Manuel Granada, ES 5 20
Buschmann, Helmut H Sant Just Desvern, ES 20 84
Nieto-López, Francisco Rafael Granada, ES 2 6
Vela-Hernandez, José-Miguel Barcelona, ES 3 6
Zamanillo-Castanedo, Daniel Barcelona, ES 24 99

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation